Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
    • IPOs
  • InderesTV
  • Forum
  • Discovery
  • Om os
    • Fulgte selskaber
    • Team

Episurf Medical

0,07 SEK

+18,18 %

Mindre end 1K følgere

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
+18,18 %
+76,15 %
+75,20 %
+75,20 %
+77,11 %
-25,58 %
-93,35 %
-96,39 %
-98,20 %

Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The company aims to create value growth through the acquisition and management of Nordic properties. The company also has a medical technology business based on the personalized implant Episealer® and associated surgical instruments, which are used to treat cartilage damage in joints. Episurf Medical's headquarters are located in Stockholm, Sweden.

Læs mere
Markedsværdi
182,68 mio. SEK
Aktieomsætning
1,17 mio. SEK
Omsætning
13,5 mio.
EBIT %
-428,89 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
13.4
2026

Ekstraordinær generalforsamling '26

25.4
2026

Generalforsamling '26

25.5
2026

Delårsrapport Q1'26

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Selskabsmeddelelsefor 21 timer siden

Episurf Medical Acquires Property Portfolio with an Agreed Property Value of SEK 697 Million from Mofast AB

Episurf Medical
Selskabsmeddelelse20.3.2026, 16.30

Episurf Medical AB's 2025 annual report is now available

Episurf Medical
Selskabsmeddelelse11.3.2026, 07.30

Notice of Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse5.3.2026, 07.30

Episurf Medical changes date for Annual General Meeting and financial reporting

Episurf Medical
Selskabsmeddelelse27.2.2026, 10.45

Change in number of shares and votes in Episurf Medical

Episurf Medical
Pressemeddelelse25.2.2026, 07.30

New US patent approval for Episurf Medical

Episurf Medical
Selskabsmeddelelse24.2.2026, 09.15

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertible debentures and warrants as part of the consideration for the acquisition of real estate assets

Episurf Medical
Selskabsmeddelelse23.2.2026, 15.15

Episurf Medical AB announces outcome of exercise of warrants of series TO14 B

Episurf Medical
Selskabsmeddelelse23.2.2026, 07.30

Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2026

Episurf Medical
Selskabsmeddelelse10.2.2026, 09.40

Episurf Medical announces leadership changes effective from 11 February 2026

Episurf Medical
Selskabsmeddelelse10.2.2026, 08.55

Press release from extraordinary general meeting in Episurf Medical AB (publ)

Episurf Medical
Pressemeddelelse9.2.2026, 07.30

The exercise period for warrants of series TO14 B in Episurf commences today

Episurf Medical
Selskabsmeddelelse6.2.2026, 07.30

Episurf: YEAR-END REPORT 1 JANUARY - 31 DECEMBER 2025

Episurf Medical
Selskabsmeddelelse26.1.2026, 07.00

Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo

Episurf Medical
Selskabsmeddelelse8.1.2026, 16.50

Notice of Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical
Selskabsmeddelelse8.1.2026, 16.40

Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change

Episurf Medical
Selskabsmeddelelse30.12.2025, 13.35

Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants

Episurf Medical
Pressemeddelelse18.11.2025, 10.45

Update on Episurf Medical's MTP implant

Episurf Medical
Pressemeddelelse4.11.2025, 07.45

Episurf's implants market approved in Singapore

Episurf Medical
Selskabsmeddelelse2.11.2025, 20.30

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.